Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer Meeting Abstract
| Authors: | Skoulidis, F.; Arbour, K. C.; Hellmann, M. D.; Patil, P. D.; Marmarelis, M. E.; Awad, M. M.; Murray, J. C.; Hellyer, J.; Gainor, J. F.; Dimou, A.; Bestvina, C. M.; Shu, C. A.; Riess, J. W.; Blakely, C. M.; Pecot, C. V.; Mezquita, L.; Tabbo, F.; Scheffler, M.; Papadimitrakopoulou, V.; Heymach, J. |
| Abstract Title: | Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 6s |
| Language: | English |
| ACCESSION: | WOS:000487345803487 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.102 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 102 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work